Clinical Trials Logo

Metastatic Sarcoma clinical trials

View clinical trials related to Metastatic Sarcoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06298916 Not yet recruiting - Colorectal Cancer Clinical Trials

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

PHANTOM
Start date: May 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open-label, prospective Phase 1/2a study to assess safety and tolerability, establish dosimetry and to identify an optimal imaging dose (radioactivity and mass dose) and imaging time window of 64Cu-LNTH-1363S (64Cu Radiolabeled FAPi PET/CT Imaging Agent) and to compare its imaging biodistribution with FAP expression by immunohistochemistry (IHC) in patients with sarcomas or GIT cancers. The study will be conducted in 2 parts (Part 1 and Part 2).

NCT ID: NCT06235125 Not yet recruiting - Osteosarcoma Clinical Trials

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Cytalux
Start date: January 20, 2024
Phase: Phase 1
Study type: Interventional

Pediatric subjects aged 6-17 with biopsy confirmed cancer and imaging findings suspicious for pulmonary metastatic disease scheduled to undergo pulmonary metastasectomy via and open or minimally invasive approach.

NCT ID: NCT05835154 Not yet recruiting - Sarcoma Clinical Trials

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information about sarcoma patients that have had surgery to either save or remove a limb may help doctors learn more about a patient's mobility needs. Using an advance care planning mobility needs assessment may help improve the quality of life in patients with sarcoma by helping them plan for their future mobility needs.

NCT ID: NCT04199026 Not yet recruiting - Metastatic Sarcoma Clinical Trials

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Start date: January 31, 2025
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies the side effects of implanting and removing a microdevice in patients with sarcomas that have spread to other places in the body (metastatic) or have come back (recurrent). Microdevices are rice-sized devices that are implanted into tumor tissue and are loaded with 10 different drugs that are delivered at very small doses, or "microdoses," which may only affect a very small, local area inside the tumor. The purpose of this study is to determine which drugs delivered in the microdevice affect tumor tissue in patients with sarcomas.